Isidro Jarque

机构：Hospital Universitari i Politècnic La Fe · ORCID：0000-0001-5673-4490

发表论文 287 篇 · 总被引 6572 次 · h-index 40

代表论文

• Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (2025 · Nature Cancer · 被引 52)
• Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) (2023 · Blood · 被引 50)
• Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice (2024 · Blood · 被引 33)
• Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma (2024 · Journal of Clinical Oncology · 被引 15)
• S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (2023 · HemaSphere · 被引 12)
• Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection (2023 · Haematologica · 被引 7)